Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
12/25/2008 | US20080318922 Bicyclic Pyrrole Derivatives |
12/25/2008 | US20080318920 Deuterium-enriched ezetimibe |
12/25/2008 | US20080318916 Novel alpha glucosidase inhibitors from lichens |
12/25/2008 | US20080318908 Use of gaba and gabab agonists |
12/25/2008 | US20080318897 Composition Containing Swelling Agent Composed of Swellable Water-Soluble Polysaccharide, and Food, Anti-Obesity Agent and Constipation Alleviator Each Containing the Composition |
12/25/2008 | US20080318874 Novel Cyclohexane Derivative, Prodrug Thereof and Salt Thereof, and Therapeutic Agent Containing the Same for Diabetes |
12/25/2008 | US20080318870 Synthetic bile acid compositions and methods |
12/25/2008 | US20080318866 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome |
12/25/2008 | US20080318861 Mucosal Delivery of Stabilized Formulations of Exendin |
12/25/2008 | US20080318851 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
12/25/2008 | US20080318845 Selective Vpac2 Receptor Peptide Agonists |
12/25/2008 | US20080318838 Peptides |
12/25/2008 | US20080318202 Chimeric pancreas |
12/25/2008 | US20080317888 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis |
12/25/2008 | US20080317882 Composistion Comprising Fremented tea Extract as the Main Component and Having Effect of Elevation Adiponectin Level |
12/25/2008 | US20080317880 Plant isoflavone and isoflavanone o-methyltransferase genes |
12/25/2008 | US20080317868 Composition for improving membrane composition and functioning cells |
12/25/2008 | US20080317847 Hydrostatic delivery system for controlled delivery of agent |
12/25/2008 | US20080317767 Tripartitle Raftophilic Strutures and their Use |
12/25/2008 | US20080317734 Nutraceutical compositions and methods with biologically active ingredients |
12/25/2008 | US20080317726 Proteases for Pharmaceutical Use |
12/25/2008 | US20080317701 Phosphate Ion Adsorbent |
12/24/2008 | WO2008157752A1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
12/24/2008 | WO2008157635A2 Synthetic bile acid composition, method, and preparation |
12/24/2008 | WO2008156869A2 Sirtuin modulating thiazolopyridine compounds |
12/24/2008 | WO2008156866A1 Sirtuin modulating imidazothiazole compounds |
12/24/2008 | WO2008156601A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases |
12/24/2008 | WO2008156174A1 Pyrazinamide compound |
12/24/2008 | WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
12/24/2008 | WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
12/24/2008 | WO2008155900A1 Glp-1 peptide having sugar chain attached thereto |
12/24/2008 | WO2008155467A1 Transmembrane prostatic acid phosphatase |
12/24/2008 | WO2008155403A2 Use of leptin in the prevention of unhealthy food habits and cardiovascular diseases |
12/24/2008 | WO2008129529A3 Cannabinoid for the treatment of neuronal damage in diabetic patients |
12/24/2008 | WO2008070692A8 Bicyclic compounds and use as antidiabetics |
12/24/2008 | WO2008060476A3 Nitrogen-containing heterocyclic compounds and methods of use thereof |
12/24/2008 | WO2008057529A3 Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp) |
12/24/2008 | WO2008019368A3 Albumin-insulin fusion proteins |
12/24/2008 | EP2006300A2 Characterization of a calcium channel family |
12/24/2008 | EP2006286A2 Isoxazole derivative and isothiazole derivative having inhibitory activity on 11 beta -hydroxysteroid dehydrogenase type i |
12/24/2008 | EP2006284A1 Dicyclooctane derivates, preparation processes and medical uses thereof |
12/24/2008 | EP2005994A1 Functional foodstuff product |
12/24/2008 | EP2005967A1 Use of leptin in the treatment of alterations in food habits |
12/24/2008 | EP2005964A2 The medicament for treating hyperphospheremia and preparation thereof |
12/24/2008 | EP2004658A1 Condensed imidazole derivatives as aromatase inhibitors |
12/24/2008 | EP2004657A1 Condensed imidazole derivatives as aldosterone synthase inhibitors |
12/24/2008 | EP2004643A1 Organic compounds |
12/24/2008 | EP2004619A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases |
12/24/2008 | EP2004617A2 Ceramide kinase modulation |
12/24/2008 | EP2004604A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators |
12/24/2008 | EP2004597A2 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain |
12/24/2008 | EP2004593A1 Improved crystalline material |
12/24/2008 | EP2004186A2 Varenicline standards and impurity controls |
12/24/2008 | EP2004152A2 Multi-membrane immunoisolation system for cellular transplant |
12/24/2008 | EP2004138A1 Gastric raft composition comprising preferably processed starches for inducing satiety |
12/24/2008 | EP2003991A1 Novel nutraceutical compositions |
12/24/2008 | EP2003966A2 Anthracenedione compounds |
12/24/2008 | EP1627866B1 Carboxylic acid compound and medicine containing the same |
12/24/2008 | EP1620425B1 Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists |
12/24/2008 | EP1601669B1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
12/24/2008 | EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
12/24/2008 | EP1441746B1 Composition and method |
12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
12/24/2008 | DE102007029042A1 Pharmazeutische Zusammensetzung mit einem Trihydroxychromenone-Derivate A pharmaceutical composition comprising a Trihydroxychromenone derivatives |
12/24/2008 | CN101331131A Pyrrolo [2, 3-b] pyridine derivatives as h3 receptor modulators |
12/24/2008 | CN101331122A Salts of modulators of PPAR and methods of treating metabolic disorders |
12/24/2008 | CN101331120A Novel heterocycle compounds |
12/24/2008 | CN101330929A Inhibitor of transplanted islet dysfunction in islet transplantation |
12/24/2008 | CN101330921A An extract from xylocarpus useful for the treatment of diabetes and dyslipidemia |
12/24/2008 | CN101330919A Pharmaceutical composition including (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrim idin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid |
12/24/2008 | CN101328487A Preparation of fermentation liquor of Coprinus comatus liquid conversion mulberry leaf and use thereof |
12/24/2008 | CN101328472A Epidermal growth factor culture fluid, externally used drug for curing diabetes trauma using the culture fluid and preparation of the externally used drug |
12/24/2008 | CN101328470A Rhamnose bacterium lacticum grx10 having cholesterol lowering and antibacterial functions, preparation and use thereof |
12/24/2008 | CN101328221A Hypoglycemic polypeptide fused protein, structure and use of derivate thereof |
12/24/2008 | CN101328157A Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity |
12/24/2008 | CN101328152A Piperazidine compound and pyridine compound |
12/24/2008 | CN101327321A Soft capsules containing lactase |
12/24/2008 | CN101327316A Formulation for treating and preventing acalcerosis |
12/24/2008 | CN101327310A Chinese medicinal composition for treating hyperlipemia and preparation thereof |
12/24/2008 | CN101327303A Long life fat-reducing navel plaster |
12/24/2008 | CN101327301A Pharmaceutical combination for preventing birth-defect and improving memory |
12/24/2008 | CN101327300A Pharmaceutical combination for preventing birth-defect and improving memory |
12/24/2008 | CN101327299A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
12/24/2008 | CN101327292A Pharmaceutical combination for preventing birth-defect and improving memory |
12/24/2008 | CN101327291A Pharmaceutical combination for preventing birth-defect and improving memory |
12/24/2008 | CN101327290A Pharmaceutical combination for preventing birth-defect and improving memory |
12/24/2008 | CN101327285A Pharmaceutical combination for preventing birth-defect and improving memory |
12/24/2008 | CN101327251A Pharmaceutical combination for preventing birth-defect and improving memory |
12/24/2008 | CN101327246A Radix astragali medicinal materials, intermediate body and method for testing fingerprint of formulation thereof as well as standard fingerprint |
12/24/2008 | CN101327244A Decolored and debitterized Momordica grosvenori extract and preparation method thereof |
12/24/2008 | CN101327243A Pharmaceutical combination for preventing birth-defect and improving memory |
12/24/2008 | CN101327240A Pharmaceutical combination for preventing birth-defect and improving memory |
12/24/2008 | CN101327239A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory |
12/24/2008 | CN101327232A Method for preparing Hippophae rhamnoides flavones separated and purified by polyamide and uses thereof |
12/24/2008 | CN101327230A Oral medicament for treating diabetes |
12/24/2008 | CN101327228A Low-acid gingko flavones and extracting method thereof |
12/24/2008 | CN101327225A Bee honey acid composition and preparation method and uses thereof |
12/24/2008 | CN101327221A Medical use of Ophiopogon root saponin D as tissue factor pathway inhibitor |
12/24/2008 | CN101327214A Medicine use of isoquinoline alkaloids as tissue factor inhibitor |
12/24/2008 | CN101327210A Use of black bean peel anthocyanidin in preparing medicament or food for preventing and treating diabetes and vascular complication |